Clinical trial
GLP-2 Mediated Increased SMA Blood Flow in Patients With Short Bowel Syndrome
NCT00673751 is registered in ClinicalTrials.gov with Glostrup University Hospital, Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GLP-2 Mediated Increased SMA Blood Flow in Patients With Short Bowel Syndrome
- Lead sponsor
- Glostrup University Hospital, Copenhagen
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 8 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.